Investment success in public health: An analysis of the cost-effectiveness and cost-benefit of the Global Programme to Eliminate Lymphatic Filariasis
<h4>Background</h4> <p>It has been estimated that US$154 million per year will be required during 2015–2020 to continue the Global Programme to Eliminate Lymphatic Filariasis (GPELF). In light of this, it is important to understand the current value of the programme. In the paper,...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Oxford University Press
2016
|